Literature DB >> 21617993

Teriparatide increases the maturation of circulating osteoblast precursors.

P D'Amelio1, C Tamone, F Sassi, L D'Amico, I Roato, S Patanè, M Ravazzoli, L Veneziano, R Ferracini, G P Pescarmona, G C Isaia.   

Abstract

UNLABELLED: This study shows that teriparatide promotes the circulating osteoblast (OB) precursor degree of maturation in patients affected by postmenopausal osteoporosis.
INTRODUCTION: Anabolic treatment with teriparatide has proven effective for the therapy of postmenopausal osteoporosis and significantly reduces the risk of non-vertebral fragility fractures. The aim of this study was to investigate the effect of teriparatide on circulating OB precursors.
METHODS: We evaluated by flow cytometry and real-time PCR the expression of OBs typical markers in peripheral blood mononuclear cells during treatment with teriparatide plus calcium and vitamin D, raloxifene plus calcium and vitamin D or calcium and vitamin D alone at various time points. Serum bone alkaline phosphatase and osteocalcin (OC) were measured as markers of bone turnover.
RESULTS: Our results show that circulating OB precursors are more numerous and more immature in patients affected by fragility fractures than in osteoporotic patients without fractures. We also show that teriparatide treatment increases the expression of alkaline phosphatase and of OC in OB precursors; thus, it increases their degree of maturation.
CONCLUSIONS: We suggest that teriparatide acts as anabolic agents also by promoting the maturation of OB precursors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617993     DOI: 10.1007/s00198-011-1666-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  36 in total

1.  A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide.

Authors:  H Jüppner; A B Abou-Samra; M Freeman; X F Kong; E Schipani; J Richards; L F Kolakowski; J Hock; J T Potts; H M Kronenberg
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

2.  Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women.

Authors:  Anita Undale; Bhuma Srinivasan; Matthew Drake; Louise McCready; Elizabeth Atkinson; James Peterson; B Lawrence Riggs; Shreyasee Amin; U I Modder; U I Moedder; Sundeep Khosla
Journal:  Bone       Date:  2010-03-31       Impact factor: 4.398

3.  Circulating osteoblast-lineage cells in humans.

Authors:  Guiti Z Eghbali-Fatourechi; Jesse Lamsam; Daniel Fraser; David Nagel; B Lawrence Riggs; Sundeep Khosla
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

4.  Characterization of circulating osteoblast lineage cells in humans.

Authors:  Guiti Z Eghbali-Fatourechi; Ulrike I L Mödder; Natthinee Charatcharoenwitthaya; Arunik Sanyal; Anita H Undale; Jackie A Clowes; James E Tarara; Sundeep Khosla
Journal:  Bone       Date:  2007-01-04       Impact factor: 4.398

5.  Second messenger signaling in the regulation of collagenase production by osteogenic sarcoma cells.

Authors:  R Civitelli; K A Hruska; J J Jeffrey; A J Kahn; L V Avioli; N C Partridge
Journal:  Endocrinology       Date:  1989-06       Impact factor: 4.736

6.  Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model.

Authors:  Ken Kumagai; Amit Vasanji; Judith A Drazba; Robert S Butler; George F Muschler
Journal:  J Orthop Res       Date:  2008-02       Impact factor: 3.494

7.  Wnt pathway genes in osteoporosis and osteoarthritis: differential expression and genetic association study.

Authors:  J Velasco; M T Zarrabeitia; J R Prieto; J L Perez-Castrillon; M D Perez-Aguilar; M I Perez-Nuñez; C Sañudo; J Hernandez-Elena; I Calvo; F Ortiz; J Gonzalez-Macias; J A Riancho
Journal:  Osteoporos Int       Date:  2009-04-17       Impact factor: 4.507

8.  Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis.

Authors:  Mario Gössl; Ulrike I Mödder; Elizabeth J Atkinson; Amir Lerman; Sundeep Khosla
Journal:  J Am Coll Cardiol       Date:  2008-10-14       Impact factor: 24.094

9.  Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells.

Authors:  J C Clohisy; D K Scott; K D Brakenhoff; C O Quinn; N C Partridge
Journal:  Mol Endocrinol       Date:  1992-11

10.  Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.

Authors:  A B Abou-Samra; H Jüppner; T Force; M W Freeman; X F Kong; E Schipani; P Urena; J Richards; J V Bonventre; J T Potts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more
  14 in total

1.  IGF-1 Receptor Expression on Circulating Osteoblast Progenitor Cells Predicts Tissue-Based Bone Formation Rate and Response to Teriparatide in Premenopausal Women With Idiopathic Osteoporosis.

Authors:  Adi Cohen; Stavroula Kousteni; Brygida Bisikirska; Jayesh G Shah; J Sanil Manavalan; Robert R Recker; Joan Lappe; David W Dempster; Hua Zhou; Donald J McMahon; Mariana Bucovsky; Mafo Kamanda-Kosseh; Julie Stubby; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2017-03-23       Impact factor: 6.741

Review 2.  [Hypophosphatasia : What is currently available for treatment?]

Authors:  T Schmidt; M Amling; F Barvencik
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

3.  Bone stock reconstruction for huge bone loss using allograft-bones, bone marrow, and teriparatide in an infected total knee arthroplasty.

Authors:  Masataka Nishikawa; Shoichi Kaneshiro; Kenji Takami; Hajime Owaki; Takeshi Fuji
Journal:  J Clin Orthop Trauma       Date:  2018-03-08

4.  Adipose-Derived Stromal Vascular Fraction/Xenohybrid Bone Scaffold: An Alternative Source for Bone Regeneration.

Authors:  Ilaria Roato; Dimas Carolina Belisario; Mara Compagno; Laura Verderio; Anna Sighinolfi; Federico Mussano; Tullio Genova; Francesca Veneziano; Gianni Pertici; Giuseppe Perale; Riccardo Ferracini
Journal:  Stem Cells Int       Date:  2018-04-29       Impact factor: 5.443

5.  A Feasibility Study to Evaluate Bacillus subtilis as a Host for Producing Recombinant Human Parathyroid Hormone.

Authors:  Mahdi Karimi; Farida Behzadian; Hamideh Rouhaninejad; Sanaz Yari
Journal:  Avicenna J Med Biotechnol       Date:  2018 Jul-Sep

6.  Extremely elevated serum alkaline phosphatase level upon treatment with teriparatide: a case report.

Authors:  Ali Javinani; Hamid Reza Aghaei Meybodi; Hoda Kavosi
Journal:  J Med Case Rep       Date:  2020-07-03

Review 7.  Osteoporosis - a current view of pharmacological prevention and treatment.

Authors:  Subhajit Das; Julie C Crockett
Journal:  Drug Des Devel Ther       Date:  2013-05-31       Impact factor: 4.162

Review 8.  Management of chronic pain in osteoporosis: challenges and solutions.

Authors:  Teresa Paolucci; Vincenzo Maria Saraceni; Giulia Piccinini
Journal:  J Pain Res       Date:  2016-04-01       Impact factor: 3.133

9.  Deficient invariant natural killer T cells had impaired regulation on osteoclastogenesis in myeloma bone disease.

Authors:  Fengjuan Jiang; Hui Liu; Zhaoyun Liu; Siyang Yan; Jin Chen; Qing Shao; Lijuan Li; Jia Song; Guojin Wang; Zonghong Shao; Rong Fu
Journal:  J Cell Mol Med       Date:  2018-02-23       Impact factor: 5.310

10.  Type 2 diabetes affects bone cells precursors and bone turnover.

Authors:  Francesca Sassi; Ilaria Buondonno; Chiara Luppi; Elena Spertino; Emanuela Stratta; Marco Di Stefano; Marco Ravazzoli; Gianluca Isaia; Marina Trento; Pietro Passera; Massimo Porta; Giovanni Carlo Isaia; Patrizia D'Amelio
Journal:  BMC Endocr Disord       Date:  2018-08-08       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.